Skip to main content
RNAZ logo

RNAZ · Transcode Therapeutics, Inc. · Held by Funds

Track RNAZ — free
$1.66 -0.04 (-2.35%)
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 20 20.23K Avg daily vol (3M) 53.41K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of RNAZ by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.10% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.06% 10,182
Index ETFs 0.04% 6,545
Active ETFs 0.00% 0
Active funds 0.00% 0
Unclassified 0.00% 0
All registered funds 0.10% 16,727
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding RNAZ

5 fund positions
Fund Balance Value % of Fund Open
Showing 1–5 of 5 positions
Key facts CIK 1829635 CUSIP 89357L501 13F (30d) 1 filings 1 filers Visit website Investor relations